seed
Stage
2
Investors
About
AHEAD Medicine develops AI-powered software to automate and accelerate flow cytometry analysis for medical research, clinical diagnostics, and quality control in cell therapy.
Explore AHEAD Medicine's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.